1. 2508 Three-arm phase II randomized trial of docetaxel monotherapy or combined with ramucirumab or icrucumab in second-line locally advanced or metastatic urothelial carcinoma. (September 2015) Authors: Petrylak, D.P.; Tagawa, S.T.; Kohli, M.; Eisen, A.; Canil, C.; Sridhar, S.S.; Spira, A.; Yu, E.Y.; Burke, J.M.; Shaffer, D.; Pan, C.X.; Kim, J.J.; Aragon-Ching, J.B.; Tang, S.; Zhang, H.; Cavanaugh, C.T.; Kauh, J.S.; Walgren, R.A.; Chi, K.N. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S476 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 2523 Feasibility analysis of pathology and genetic yield from a prospective trial of tissue biopsies in metastatic castrate resistant prostate cancer. (September 2015) Authors: Jimenez, R.; Sicotte, H.; Barman, P.; Sinnwell, J.; Eiken, P.; Atwell, T.; McMenomy, B.; Tan, W.; Wu, K.; Bryce, A.; Ho, T.; Pitot, H.; Quevedo, J.F.; Costello, B.; Dronca, R.; Moynihan, T.; Wang, L.; Qin, R.; Carlson, R.; Kohli, M. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S482 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 2573 Impact of biopsy of metastases on circulating tumor cell (CTC) counts in castrate resistant prostate cancer (CRPC). (September 2015) Authors: Kohli, M.; Tan, W.; Eiken, P.; McMenomy, B.; Atwell, T.; Carlson, R.; Campion, M.; Wang, L.; Costello, B.; Pitot, H.; Quevedo, F.; Ho, T.; Bryce, A.; Qin, R.; Paz-Fumagalli, R.; Moynihan, T.; Dronca, R.; Liu, M. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S502 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. An audit of the effectiveness of PCSK9 inhibition in reducing cholesterol in patients attending lipid clinics. (September 2017) Authors: Kohli, M.; McMahon, Z.; Ramachandran, R.; Crook, M.A.; Reynolds, T.M.; Wierzbicki, A.S. Journal: Atherosclerosis Issue: Volume 28(2017) Page Start: e11 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. How far have we come? Artificial intelligence for chest radiograph interpretation. Issue 5 (May 2019) Authors: Kallianos, K.; Mongan, J.; Antani, S.; Henry, T.; Taylor, A.; Abuya, J.; Kohli, M. Journal: Clinical radiology Issue: Volume 74:Issue 5(2019) Page Start: 338 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Is Suppression of Apoptosis a New Therapeutic Target in Sepsis?. Issue 2 (March 2013) Authors: Harjai, M.; Bogra, J.; Kohli, M.; Pant, A. B. Journal: Anaesthesia and intensive care Issue: Volume 41:Issue 2(2013) Page Start: 175 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Pro-protein subtilisin kexin-9 (PCSK9) inhibition in practice: Lipid clinic experience in 2 contrasting UK centres. (August 2018) Authors: Wierzbicki, A.; Kohli, M.; Patel, K.; McMahon, Z.; Ramachandran, R.; Crook, M.; Reynolds, T. Journal: Atherosclerosis Issue: Volume 275(2018) Page Start: e100 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Test performance of genetic testing in familial hypercholesterolaemia in a local lipid clinic. (October 2019) Authors: Mirzazadeh, M.; Kohli, M.; Ferns, G. Journal: Atherosclerosis Issue: Volume 38(2019) Page Start: e8 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗